KBC Group’s Zai Lab ZLAB Stock Holding History

KBC Group’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,770	Closed	-$60K	–	1921
2024 Q1	$60K	Hold	3,770	–	–	﹤0.01%	1447
2023 Q4	$103K	Hold	3,770	–	–	﹤0.01%	1055
2023 Q3	$92K	Sell	3,770 -26,343	-87%	-$702K	﹤0.01%	1049
2023 Q2	$835K	Buy	30,113 +16,992	+130%	+$556K	﹤0.01%	713
2023 Q1	$436K	Hold	13,121	–	–	﹤0.01%	802
2022 Q4	$403K	Hold	13,121	–	–	﹤0.01%	793
2022 Q3	$449K	Hold	13,121	–	–	﹤0.01%	780
2022 Q2	$455K	Hold	13,121	–	–	﹤0.01%	782
2022 Q1	$577K	Hold	13,121	–	–	﹤0.01%	783
2021 Q4	$825K	Buy	13,121 +3,328	+34%	+$282K	﹤0.01%	756
2021 Q3	$1.03M	Sell	9,793 -9,793	-50%	-$1.41M	﹤0.01%	754
2021 Q2	$3.47M	Buy	19,586 +1,984	+11%	+$319K	0.01%	691
2021 Q1	$2.35M	Sell	17,602 -3,064	-15%	-$474K	﹤0.01%	731
2020 Q4	$15.4M	Buy	20,666 +10,840	+110%	+$1.1M	0.01%	705
2020 Q3	$818K	Hold	9,826	–	–	﹤0.01%	832
2020 Q2	$808K	Buy	+9,826	New	+$665K	﹤0.01%	857

Other funds holding ZLAB

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KBC Group's ZLAB Position: Q2 2024 in Review

KBC Group sold out of Zai Lab (ZLAB) in Q2 2024, closing a stake of 3,770 shares — an estimated $60K sold.

KBC Group first reported a position in ZLAB in Q2 2020 and held it in 16 quarters. The position peaked at $15.4M in Q4 2020. 105 funds tracked by Wall St. Rank hold ZLAB as of Q2 2024.

KBC Group reported no remaining Zai Lab position as of Q2 2024 after selling out during the quarter.
KBC Group sold 3,770 Zai Lab shares in Q2 2024, an estimated $60K.
KBC Group first reported a position in Zai Lab in Q2 2020 and held it in 16 quarters.
KBC Group's Zai Lab position peaked at $15.4M in Q4 2020.
105 funds tracked by Wall St. Rank held Zai Lab as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.